James Xue
Chief Executive Officer bij CANBRIDGE PHARMACEUTICALS INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
James Xue is the founder of CANbridge Life Sciences Ltd.
(2012) and CANbridge Pharmaceuticals Inc. (2018), where he holds the titles of Chairman, President & Chief Executive Officer and Chairman & Chief Executive Officer, respectively.
He is also the founder of CANbridge Consulting LLC.
Currently, he holds the position of President, Secretary & Director at Canbridge Pharmaceuticals, Inc. (United States), Deputy Director General at China Alliance For Rare Diseases, Deputy Director at Shanghai Foundation For Rare Disease, Member-Leadership Council at Peking University Health Science Center, Member at The BayHelix Group, and Member-Leadership Council at the University of Michigan Medical School.
His former position was as General Manager-Genzyme China at Genzyme Corp.
He received his doctorate from Brown University in 1997, his graduate degree from the University of California in 1998, his MBA from the University of Virginia Darden School of Business in 2002, and his undergraduate degree from Peking University School of Pharmaceutical Sciences in 1992.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-11-2022 | 41 775 430 ( 9.83% ) | 2 M $ | 31-03-2024 |
Actieve functies van James Xue
| Bedrijven | Functie | Begin |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Chief Executive Officer | 30-01-2018 |
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Chief Executive Officer | 12-06-2012 |
| CANbridge Consulting LLC | Founder | - |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | President | - |
| China Alliance For Rare Diseases | Corporate Officer/Principal | - |
| Shanghai Foundation For Rare Disease | Corporate Officer/Principal | - |
| University of Michigan Medical School | Corporate Officer/Principal | 01-08-2017 |
| Peking University Health Science Center | Corporate Officer/Principal | 01-08-2017 |
| The BayHelix Group | Corporate Officer/Principal | - |
Eerdere bekende functies van James Xue
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van James Xue
| Brown University | Doctorate Degree |
| University of California | Graduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
| Peking University School of Pharmaceutical Sciences | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| The BayHelix Group | |
CANbridge Life Sciences Ltd.
CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Health Technology |
| CANbridge Consulting LLC | |
Canbridge Pharmaceuticals, Inc. (United States)
Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Health Technology |
| China Alliance For Rare Diseases | |
| Shanghai Foundation For Rare Disease |
